Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A genetic variant in the promoter of CD46 is associated with the risk and prognosis of hepatocellular carcinoma.

Molecular carcinogenesis - 1 Nov 2020

Liu Fei, Luo Limei, Liu Zhongjian, Wu Sisi, Zhang Wei, Li Qin, Peng Yufu, Wei Yonggang, Li Bo

Abstract excerpt

CD46 (also known as membrane cofactor protein), which is a member of the membrane-bound complement regulatory protein family, has been reported to cause cancer cells to escape complement-dependent cytotoxicity. However, the association between CD46 polymorphisms and the risk of hepatocellular carcinoma (HCC) has not been investigated. This two-stage association study was conducted to assess the relationship...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Carcinoma, Hepatocellular

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Follow-Up Studies

Share to Gene Expression Regulation, Neoplastic

Share to Liver Neoplasms

Share to Membrane Cofactor Protein

Share to Survival Rate

Share to Tumor Cells, Cultured

Source

Identifiers

PMID: 32869896
DOI: 10.1002/mc.23252

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A genetic variant in the promoter of CD46 is associated with the risk and prognosis of hepatocellular carcinoma.PMID 32869896Read ↗

A Promoter Polymorphism in the CD46 Complement Regulatory Protein Gene Is Associated With Acute Renal Allograft Rejection.Semantic proximity Read ↗

Complement regulator CD46: genetic variants and disease associations.Semantic proximity Read ↗

A novel functional polymorphism in the Cdc6 promoter is associated with the risk for hepatocellular carcinoma.Semantic proximity Read ↗

Association Between Promoter Polymorphisms in CD46 and CD59 in Kidney Donors and Transplant Outcome.Semantic proximity Read ↗

rs3746444 polymorphism and susceptibility to hepatocellular carcinoma: evidence from published studies.Semantic proximity Read ↗

Mutations in membrane cofactor protein (CD46) gene in Indian children with hemolytic uremic syndromeSemantic proximity Read ↗

Tissue-specific and allelic expression of the complement regulator CD46 is controlled by alternative splicing.Semantic proximity Read ↗

Mutations in CD46, a complement regulatory protein, predispose to atypical HUS.Semantic proximity Read ↗

Susceptibility to hepatocellular carcinoma in the Chinese population--associations with interleukin-6 receptor polymorphism.Semantic proximity Read ↗

Genetic analysis of membrane cofactor protein (CD46) of the complement system in women with and without preeclamptic pregnancies.Semantic proximity Read ↗

CD46 Genetic Variability and HIV-1 Infection Susceptibility.Semantic proximity Read ↗

CFI-rs7356506 is a genetic protective factor for acute anterior uveitis in Chinese patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.